MACROPORE PURICEL LIPOPLASTY SYSTEM— 510(k) K042261
Substantially EquivalentMacropore Biosurgery, Inc.
FDA 510(k) clearance K042261 for MACROPORE PURICEL LIPOPLASTY SYSTEM, Substantially Equivalent on 2004-09-20. Applicant: Macropore Biosurgery, Inc.. Device class: 2.
Clearance details
- Applicant
- Macropore Biosurgery, Inc.
- Product code
- Code QPB
- Device class
- Class 2
- Regulation
- 21 CFR 878.5040
- Advisory panel
- General, Plastic Surgery
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- San Diego, CA, US
Recent devices under product code QPB
view allMore clearances from Macropore Biosurgery, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.